Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 24590622)

1.

Evidence for divergent effects of neurodegeneration in Huntington's disease on attentional selection and neural plasticity: implications for excitotoxicity.

Beste C, Stock AK, Ness V, Hoffmann R, Saft C.

Brain Struct Funct. 2015 May;220(3):1437-47. doi: 10.1007/s00429-014-0735-7. Epub 2014 Mar 4.

PMID:
24590622
2.

Stimulus-response compatibility in Huntington's disease: a cognitive-neurophysiological analysis.

Beste C, Saft C, Andrich J, Gold R, Falkenstein M.

J Neurophysiol. 2008 Mar;99(3):1213-23. doi: 10.1152/jn.01152.2007. Epub 2008 Jan 9.

3.

Faster perceptual learning through excitotoxic neurodegeneration.

Beste C, Wascher E, Dinse HR, Saft C.

Curr Biol. 2012 Oct 23;22(20):1914-7. doi: 10.1016/j.cub.2012.08.012. Epub 2012 Sep 13.

4.

Cognitive interventions to enhance neural compensation in Huntington's disease.

Andrews SC, Domínguez JF, Mercieca EC, Georgiou-Karistianis N, Stout JC.

Neurodegener Dis Manag. 2015 Apr;5(2):155-64. doi: 10.2217/nmt.14.58.

PMID:
25894879
5.

On the role of fronto-striatal neural synchronization processes for response inhibition--evidence from ERP phase-synchronization analyses in pre-manifest Huntington's disease gene mutation carriers.

Beste C, Ness V, Falkenstein M, Saft C.

Neuropsychologia. 2011 Oct;49(12):3484-93. doi: 10.1016/j.neuropsychologia.2011.08.024. Epub 2011 Sep 1.

PMID:
21906607
6.

Increased cognitive functioning in symptomatic Huntington's disease as revealed by behavioral and event-related potential indices of auditory sensory memory and attention.

Beste C, Saft C, Güntürkün O, Falkenstein M.

J Neurosci. 2008 Nov 5;28(45):11695-702. doi: 10.1523/JNEUROSCI.2659-08.2008.

7.

Changes in cognitive control in pre-manifest Huntington's disease examined using pre-saccadic EEG potentials - a longitudinal study.

Ness V, Bestgen AK, Saft C, Beste C.

J Huntingtons Dis. 2014;3(1):33-43. doi: 10.3233/JHD-130086.

PMID:
25062763
8.

3-Nitropropionic acid animal model and Huntington's disease.

Borlongan CV, Koutouzis TK, Sanberg PR.

Neurosci Biobehav Rev. 1997 May;21(3):289-93. Review.

PMID:
9168265
9.

Altered sensory experience exacerbates stable dendritic spine and synapse loss in a mouse model of Huntington's disease.

Murmu RP, Li W, Szepesi Z, Li JY.

J Neurosci. 2015 Jan 7;35(1):287-98. doi: 10.1523/JNEUROSCI.0244-14.2015.

PMID:
25568121
10.

Transient and steady-state selection in the striatal microcircuit.

Tomkins A, Vasilaki E, Beste C, Gurney K, Humphries MD.

Front Comput Neurosci. 2014 Jan 20;7:192. doi: 10.3389/fncom.2013.00192. eCollection 2013.

11.

Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease.

Novak MJ, Warren JD, Henley SM, Draganski B, Frackowiak RS, Tabrizi SJ.

Brain. 2012 Apr;135(Pt 4):1165-79. doi: 10.1093/brain/aws024.

12.

Huntington's Disease and Striatal Signaling.

Roze E, Cahill E, Martin E, Bonnet C, Vanhoutte P, Betuing S, Caboche J.

Front Neuroanat. 2011 Aug 23;5:55. doi: 10.3389/fnana.2011.00055. eCollection 2011.

13.

The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation.

Papoutsi M, Labuschagne I, Tabrizi SJ, Stout JC.

Mov Disord. 2014 Apr 15;29(5):673-83. doi: 10.1002/mds.25864. Review.

PMID:
24757115
14.

Age-Dependent Resistance to Excitotoxicity in Htt CAG140 Mice and the Effect of Strain Background.

Strong MK, Southwell AL, Yonan JM, Hayden MR, Macgregor GR, Thompson LM, Steward O.

J Huntingtons Dis. 2012 Jan;1(2):221-41. doi: 10.3233/JHD-129005.

15.

Changes in Cognitive Function in Human Aging.

Glisky EL.

In: Riddle DR, editor. Brain Aging: Models, Methods, and Mechanisms. Boca Raton (FL): CRC Press; 2007. Chapter 1.

16.

Functional connectivity modeling of consistent cortico-striatal degeneration in Huntington's disease.

Dogan I, Eickhoff CR, Fox PT, Laird AR, Schulz JB, Eickhoff SB, Reetz K.

Neuroimage Clin. 2015 Feb 27;7:640-52. doi: 10.1016/j.nicl.2015.02.018. eCollection 2015.

17.

Diagnostic criteria for Huntington's disease based on natural history.

Reilmann R, Leavitt BR, Ross CA.

Mov Disord. 2014 Sep 15;29(11):1335-41. doi: 10.1002/mds.26011. Epub 2014 Aug 27.

PMID:
25164527
18.

Targeting glutamate mediated excitotoxicity in Huntington's disease: neural progenitors and partial glutamate antagonist--memantine.

Anitha M, Nandhu MS, Anju TR, Jes P, Paulose CS.

Med Hypotheses. 2011 Jan;76(1):138-40. doi: 10.1016/j.mehy.2010.09.003. Epub 2010 Oct 12.

PMID:
20943326
19.

Plastic abnormalities in experimental Huntington's disease.

Di Filippo M, Tozzi A, Picconi B, Ghiglieri V, Calabresi P.

Curr Opin Pharmacol. 2007 Feb;7(1):106-11. Epub 2006 Oct 30. Review.

PMID:
17071137
20.

Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease.

Finke K, Bublak P, Dose M, Müller HJ, Schneider WX.

Brain. 2006 May;129(Pt 5):1137-51. Epub 2006 Feb 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk